INNOVATIVE CELL-BASED URINALYSIS FOR PATIENT ADHERENCE
创新的基于细胞的尿液分析可提高患者的依从性
基本信息
- 批准号:7880436
- 负责人:
- 金额:$ 97.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2010-09-29
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAdherenceAdultAlternative MedicineAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAscorbic AcidBiological AssayBody FluidsBotanicalsBroccoli - dietaryCellsCitiesClinicalClinical ResearchClinical TrialsColon CarcinomaComplementComplementary and alternative medicineConsumptionCranberriesCultured CellsDegradation PathwayDetectionDevelopmentDietElementsEvaluationExcretory functionFlourFoundationsFreeze DryingFundingFutureGarlicGene ExpressionGene TargetingGenesGeneticGingerGoalsHealth ProfessionalHealth SciencesHealthcareHumanHuman VolunteersImageIn VitroInflammationInhibitory Concentration 50InterventionInvestigationLeadLuc GeneLuciferasesMalignant NeoplasmsMeasurementMeasuresMediatingMethodsModalityMolecularMonitorMusNational Center for Complementary and Alternative MedicineNatureOhioOklahomaOralOutcomePatientsPharmaceutical PreparationsPhasePhase I Clinical TrialsPlacebo EffectPlacebosPomegranatePrincipal InvestigatorProcessProtocols documentationPublic HealthRandomized Clinical TrialsRaspberriesReagentRecruitment ActivityResearchResearch InfrastructureSafetySamplingSavingsScientistScreening procedureSerumServicesSignal TransductionSiteSmall Business Innovation Research GrantSpectrophotometrySystemTeaTechniquesTechnologyTestingTimeTumericUnited StatesUniversitiesUniversity HospitalsUrinalysisUrineValidationWestern BlottingWheatbasecancer cellcapsulecommercializationcompliance behaviordesigndietary supplementsdosagedrug discoverydrug testingfeedingfollow-upgenetic elementgum mastichigh throughput screeningin vivoinnovationluminescenceminimally invasivenew technologypilot trialprogramsresearch studytool
项目摘要
DESCRIPTION (provided by applicant): The scientific and commercial goal of this small business innovation research (SBIR-Phase II) proposal is to develop cell-based assays for the detection of biologically active complementary and alternative medicine (CAM) agents in body fluids. The proposed project builds on the foundation of a molecular assay designed and validated through a recent Phase I funding. The strategy of identifying CAM agents in body fluids by an in vitro bio-luminescence imaging system complements another drug-discovery technology developed at Swaasth Inc, referred to as Genetic Expression and Measurement (GEMTM). Together, these cell-based CAM agent detection technologies will enable the development of novel technologies in monitoring objective measures of adherence to study-protocol in the investigations of CAM modalities. Swaasth Inc. has
successfully developed molecular reagents and high throughput-screening infrastructure required to
identify CAM agents. It is anticipated that the availability of GEM system will make effective use of
the Phase II funding to further expand the detection of a variety of CAM agents and enhance
minimally invasive patient adherence measurements for CAM modalities in clinical settings.
描述(由申请人提供):这项小型企业创新研究(SBIR-Phase II)提案的科学和商业目标是开发基于细胞的检测方法,用于检测体液中具有生物活性的补充和替代医学(CAM)制剂。拟议的项目建立在分子测定的基础上,通过最近的第一阶段资金设计和验证。通过体外生物发光成像系统识别体液中CAM试剂的策略补充了Swaasth Inc开发的另一种药物发现技术,称为遗传表达和测量(GEMTM)。总之,这些基于细胞的CAM代理检测技术将使新技术的发展,在监测客观的措施,遵守研究方案的CAM模式的调查。斯瓦斯特公司具有
成功开发了分子试剂和高通量筛选基础设施,
识别CAM代理。预计GEM系统的可用性将有效利用
第二阶段的资金,以进一步扩大检测各种CAM代理人,并提高
临床环境中CAM模态的微创患者依从性测量。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Curcumin and turmeric attenuate arsenic-induced angiogenesis in ovo.
- DOI:
- 发表时间:2010-03
- 期刊:
- 影响因子:1.5
- 作者:P. Pantazis;A. Varman;C. Simpson‐Durand;J. Thorpe;S. Ramalingam;D. Subramaniam;C. Houchen;M. Ihnat;S. Anant;Rama P. Ramanujam
- 通讯作者:P. Pantazis;A. Varman;C. Simpson‐Durand;J. Thorpe;S. Ramalingam;D. Subramaniam;C. Houchen;M. Ihnat;S. Anant;Rama P. Ramanujam
An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells.
夏威夷姜黄的乙醇提取物:对人类结肠癌细胞具有广泛的体外抗癌活性。
- DOI:
- 发表时间:2015
- 期刊:
- 影响因子:1.5
- 作者:Dimas,Konstantinos;Tsimplouli,Chrisiida;Houchen,Courtney;Pantazis,Panayotis;Sakellaridis,Nikos;Tsangaris,GeorgeTh;Anastasiadou,Ema;Ramanujam,RamaP
- 通讯作者:Ramanujam,RamaP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAMA P RAMANUJAM其他文献
RAMA P RAMANUJAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAMA P RAMANUJAM', 18)}}的其他基金
INNOVATIVE CELL-BASED URINALYSIS FOR PATIENT ADHERENCE
创新的基于细胞的尿液分析可提高患者的依从性
- 批准号:
7433395 - 财政年份:2007
- 资助金额:
$ 97.7万 - 项目类别:
URINALYSIS FOR PATIENT COMPLIANCE TO CAM THERAPY
尿液分析以确保患者对 CAM 治疗的依从性
- 批准号:
7244224 - 财政年份:2006
- 资助金额:
$ 97.7万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 97.7万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 97.7万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 97.7万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 97.7万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 97.7万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 97.7万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 97.7万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 97.7万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 97.7万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 97.7万 - 项目类别: